Prostaglandin D_2 is a key molecule for neuroinflammation in the demyelinating diseases
Prostaglandin D_2 is a key molecule for neuroinflammation in the demyelinating diseases
批准号:
17591085
负责人:
TANIIKE Masako
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Prostaglandin (PG) D2 is well known as an inflammatory mediator. The biological actions of PGD_2 are elicited through binding to DP_1 or DP_2 receptor. Hematopoi_etic PGD synthase (HPGDS) is responsible for the production of PGD_2,and is expressed in microglia in CNS. (Mohri et al.2003). The twitcher mouse (GALC^<twi/twi>) is an authentic animal model of human globoid cell leukodystrophy (Krabbe's disease) resulting from the deficiency of galactosylceramidase. In this model, the demyelination is caused by the apoptosis of oligodendrocytes (OLs) after postnatal day (PND) 30,and is always accompanied by the activation of microglia and gliosis throughout the brain. In this study, we found that HPGDS expression was progressively upregulated in activated microglia in the GALC^<twi/twi> brain. This upregulation was accompanied by the induction of the DP_1 receptor in hypertrophic astrocytes located close to HPGDS^+ microglia. Using primary culture of glial cells, we demonstrated that activated microglia produced large amount of PGD_2 by HPGDS and that astrocytes expressed both DP_1 and DP_2 receptors and were activated by PGD_2. Furthermore, by using HPGDS- or DP_1-deficient GALC^<twi/twi> mice and GALC^<twi/twi> mice treated with an HPGDS-inhibitor, we found that the blockade of the HPGDS/PGD_2/DP signaling pathway resulted in the suppression of gliosis and oligodendroglial apoptosis. This is the first example of a PGD_2-mediated microglia/astrocyte interaction in neuroinflammation.
期刊论文(45)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1016/j.neulet.2007.04.016
发表时间:
2007-06
期刊:
Neuroscience Letters
影响因子:
2.5
作者:
[Hidetoshi Taniguchi;I. Mohri;Hitomi Okabe-Arahori;T. Kanekiyo;Kuriko Kagitani-Shimono;Kazuko Wada;Y. Urade;M. Nakayama;K. Ozono;M. Taniike]
通讯作者:
Hidetoshi Taniguchi;I. Mohri;Hitomi Okabe-Arahori;T. Kanekiyo;Kuriko Kagitani-Shimono;Kazuko Wada;Y. Urade;M. Nakayama;K. Ozono;M. Taniike
DOI:
10.1523/jneurosci.4531-05.2006
发表时间:
2006-04-19
期刊:
JOURNAL OF NEUROSCIENCE
影响因子:
5.3
作者:
[Mohri, I, Taniike, M, Urade, Y]
通讯作者:
Urade, Y
DOI:
10.1016/j.sleep.2005.04.002
发表时间:
2005-11-01
期刊:
SLEEP MEDICINE
影响因子:
4.8
作者:
[Tachibana, N, Taniike, M, Nishino, S]
通讯作者:
Nishino, S
Lipocalin-type prostaglandin D synthase (beta-trace) is upregulated in the alphaB-crystallin-positive oligodendrocytes and astrocytes in the chronic multiple sclerosis.
在慢性多发性硬化症中,脂质运载蛋白型前列腺素 D 合酶(β-痕量)在 αB-晶状体蛋白阳性少突胶质细胞和星形胶质细胞中上调。
DOI:
--
发表时间:
2006
期刊:
Neuropathol Appl Neurobiol 32(1)
影响因子:
--
作者:
[Kagitani-Shimono K, Mohri I, Oda H, Ozono K, Suzuki K, Urade Y, Taniike M.]
通讯作者:
Taniike M.
Novel mutation of gene coding for glial fibrillary acidic protein in a Japanese patient with Alexander disease
日本亚历山大病患者胶质纤维酸性蛋白编码基因的新突变
DOI:
--
发表时间:
2006
期刊:
Brain Dev 28・1
影响因子:
--
作者:
[Kawai, M, Sakai, N. et al.(8)]
通讯作者:
N. et al.(8)
共 23 条
Development of Novel Methods for Evaluating Sleep in Children by Multimodal Approaches
-
批准号:21659256
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$1.95万
-
财政年份:2009
-
负责人:TANIIKE Masako
-
依托单位:
The investigation of the anti-apoptotic mechanism of lipocalin-type prostaglandin D synthase
-
批准号:13670801
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:2001
-
负责人:TANIIKE Masako
-
依托单位:
The machanism of oligodendroglial apoptosis of in the model of the genetic demyelination.
-
批准号:11670761
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:1999
-
负责人:TANIIKE Masako
-
依托单位:
Investigation of the role of MHC class I molecule on the demyelination in a model of genetic demyelination
-
批准号:09670806
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.92万
-
财政年份:1997
-
负责人:TANIIKE Masako
-
依托单位:
海外基金